Skip to main content
Clinical Trials/ITMCTR2100004644
ITMCTR2100004644
Recruiting
Phase 1

Clinical observation on the treatment of joint swelling and pain due to the Fengtabuzu syndrome of RA by Dai medicine Longmengshahousan

ConditionsRA

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
RA
Sponsor
Yunnan Hospital of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Meet the 2010 ACR/EULAR DIAGNOSTIC criteria for RA;
  • (2\) It conforms to the diagnostic criteria of Fengtabuzu syndrome;
  • (3\) Between the ages of 18 and 70, regardless of gender;
  • (4\) the hands joint X\-ray stage I and II, joint function class I and II, III;
  • (5\) 2\.6 \< DAS28 \< 5\.1;
  • (6\) Pain or swelling of at least two wrists;
  • (7\) Patients who use hormones, hormone\-suspected substances or biological agents need to stop taking drugs for more than 3 months;
  • (8\) No non\-steroidal anti\-inflammatory drugs or topical analgesics were used at least 1 week before enrollment.
  • (9\) Voluntary subjects signed informed consent.

Exclusion Criteria

  • (1\) Patients with other rheumatic immune diseases, such as systemic lupus erythematosus, Sjogren's syndrome, and severe osteoarthritis;
  • (2\) Complicated with cardiovascular, pulmonary, liver, gastrointestinal, kidney, hematopoietic system or tumor, or complicated with various acute or chronic infections or other infectious diseases (hepatitis, tuberculosis, etc.);
  • (3\) Local skin damage, infection or trauma of the tested joint is not healed;
  • (4\) Those who did not respond to the treatment of methotrexate or leflunomide;
  • (5\) A history of contraindications to experimental drugs (pulmonary interstitial fibrosis, etc.) and allergies;
  • (6\) A history of alcoholism, drug addiction or neuropsychiatric disorders (epilepsy, depression, etc.);
  • (7\) Pregnant or lactating women who have recently had family planning;
  • (8\) Participating in other drug clinical studies.

Outcomes

Primary Outcomes

Not specified

Similar Trials